It has been reported that iNOS-KO mice and the administration of iNOS inhibitors in mice attenuate bleomycin-induced pulmonary fibrosis and lung injury [49,50], whereas, in contrast, worsening of bleomycin-induced lung injury in iNOS-KO mice has also reported [51]. This evidence concerns the gene NOS2 and pulmonary fibrosis.